Without aligned process improvements across Regulatory Affairs, Quality and Pharmacovigilance/Drug Safety, pharma companies risk limiting their overall market performance, says MAIN5’s Tobias Hitziger.
The ENGEL Group subsidiary, TMA AUTOMATION Sp. z o.o., has begun construction of a modern office and production building in the immediate vicinity of Gdansk Airport in Poland.
electronRx, a digital medicine and biomarker company driving healthcare through pulmonary innovation, has announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7–10th January.
The global pharmaceutical industry is facing unprecedented supply chain challenges in the current climate of geopolitical uncertainty. Marco Gorgas, chief technical officer, Adragos Pharma explains.
Neuraxpharm Group (Neuraxpharm) and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under Pharmathen’s long-acting therapeutic technologies (LATT) program.
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1.
Portescap’s business development manager for medical applications, Dave Beckstoffer, explains how drive systems for wearable and automatic drug delivery devices are central to the patient outcome.
